Journal article
Identifying colorectal cancer caused by biallelic MUTYH pathogenic variants using tumor mutational signatures
P Georgeson, TA Harrison, BJ Pope, SH Zaidi, C Qu, RS Steinfelder, Y Lin, JE Joo, K Mahmood, M Clendenning, R Walker, EL Amitay, SI Berndt, H Brenner, PT Campbell, Y Cao, AT Chan, J Chang-Claude, KF Doheny, DA Drew Show all
Nature Communications | Published : 2022
Abstract
Carriers of germline biallelic pathogenic variants in the MUTYH gene have a high risk of colorectal cancer. We test 5649 colorectal cancers to evaluate the discriminatory potential of a tumor mutational signature specific to MUTYH for identifying biallelic carriers and classifying variants of uncertain clinical significance (VUS). Using a tumor and matched germline targeted multi-gene panel approach, our classifier identifies all biallelic MUTYH carriers and all known non-carriers in an independent test set of 3019 colorectal cancers (accuracy = 100% (95% confidence interval 99.87–100%)). All monoallelic MUTYH carriers are classified with the non-MUTYH carriers. The classifier provides evide..
View full abstractRelated Projects (2)
Grants
Awarded by National Institutes of Health
Funding Acknowledgements
Funding from a National Health and Medical Research Council of Australia (NHMRC) project grant GNT1125269 (PI- Daniel Buchanan), and from NIH/NCI grants (U01CA137088, R01CA223498, and X01-HG009781; PI-Ulrike Peters) supported the design, analysis, and interpretation of data. Additional acknowledgements relating to co-authors and contributing studies are described in the Supplementary Methods as Supplementary Note 1.